Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Align TechnologyWBO:ALGN -1.95%84 Interest Coverage is 0 (At Loss) as of Jun. 2026. GuruFocus rates WBO:ALGN with a GF Score™ of 84/100 and a GF Value™ of €195.87 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 462 Medical Devices & Instruments companies, Align Technology ranks worse than 216450% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Align Technology's
Operating Income
for the
three
months ended in Jun. 2026 was €166 Mil. Align Technology's Interest Expense for the
three
months ended in Jun. 2026 was €0 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Align Technology Inc has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Align Technology's Interest Coverage or its related term are showing as below:
WBO:ALGN's Interest Coverage is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 16.755 * Ranked among companies with meaningful Interest Coverage only.
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Align Technology Interest Coverage Related Terms
Align Technology Interest Coverage Historical Data
* Premium members only.
The historical data trend for Align Technology's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
WBO:ALGN vs RGEN, AVTR, BAX: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Align Technology's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Align Technology Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Align Technology's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
GuruFocus does not calculate Align Technology's interest coverage with the available data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Align Technology (WBO:ALGN) has a Interest Coverage of 0 (At Loss) as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Align Technology and its competitors. Over the past decade, Align Technology's Interest Coverage has ranged from 10,000.00 to 10,000.00. According to the industry distribution chart, Align Technology ranks #999999 out of 462 companies in the Medical Devices & Instruments industry.
Is Align Technology's Interest Coverage too high?
Align Technology's current Interest Coverage is 0 (At Loss). Over the past 10 years, this metric has ranged from a low of 10,000.00 to a high of 10,000.00. Based on the distribution chart, Align Technology ranks #999999 out of 462 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Align Technology has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Align Technology's Interest Coverage compare to RGEN and AVTR?
According to the Medical Devices & Instruments industry distribution chart, Align Technology ranks #999999 out of 462 companies for Interest Coverage. This places Align Technology in the lower half of its industry. The industry median Interest Coverage is 16.76. Historically, Align Technology's own Interest Coverage has ranged from 10,000.00 to 10,000.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.76, based on 462 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Align Technology and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Align Technology's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Align Technology stock overvalued right now?
Based on GuruFocus' analysis, Align Technology (WBO:ALGN) is currently considered Significantly Undervalued. The stock's GF Value™ is €195.87, compared to a current price of €128.50 — trading 34.4% below its estimated fair value. The current Interest Coverage is 0 (At Loss). Align Technology's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Align Technology (WBO:ALGN), the current Interest Coverage is 0 (At Loss) as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Align Technology (WBO:ALGN) Overvalued in 2026?
Based on GuruFocus' analysis, Align Technology stock appears to be undervalued.
The current stock price of €128.50 is trading 34.4% below its estimated GF Value™ of €195.87.
GuruFocus considers Align Technology to be Significantly Undervalued.
Key valuation signals for WBO:ALGN:
Interest Coverage: 0 (At Loss)
GF Value™: €195.87 vs. price of €128.50 (34.4% below fair value)
No single metric tells the full story. See the WBO:ALGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
84GF Score
Get the complete analysis for WBO:ALGN
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:ALGN has been successfully added to your 
